| Title : A randomized, placebo-controlled study investigating the nicotinic alpha7 agonist, RG3487, for cognitive deficits in schizophrenia - Umbricht_2014_Neuropsychopharmacology_39_1568 |
| Author(s) : Umbricht D , Keefe RS , Murray S , Lowe DA , Porter R , Garibaldi G , Santarelli L |
| Ref : Neuropsychopharmacology , 39 :1568 , 2014 |
| Abstract : |
| PubMedSearch : Umbricht_2014_Neuropsychopharmacology_39_1568 |
| PubMedID: 24549101 |
| Title : A randomized, placebo-controlled study investigating the nicotinic alpha7 agonist, RG3487, for cognitive deficits in schizophrenia - Umbricht_2014_Neuropsychopharmacology_39_1568 |
| Author(s) : Umbricht D , Keefe RS , Murray S , Lowe DA , Porter R , Garibaldi G , Santarelli L |
| Ref : Neuropsychopharmacology , 39 :1568 , 2014 |
| Abstract : |
| PubMedSearch : Umbricht_2014_Neuropsychopharmacology_39_1568 |
| PubMedID: 24549101 |
| Title : A randomized, placebo-controlled study investigating the nicotinic alpha7 agonist, RG3487, for cognitive deficits in schizophrenia - Umbricht_2014_Neuropsychopharmacology_39_1568 |
| Author(s) : Umbricht D , Keefe RS , Murray S , Lowe DA , Porter R , Garibaldi G , Santarelli L |
| Ref : Neuropsychopharmacology , 39 :1568 , 2014 |
| Abstract : |
| PubMedSearch : Umbricht_2014_Neuropsychopharmacology_39_1568 |
| PubMedID: 24549101 |